Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases

Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNFα) exhibited lower serologic responses one-month following the second dose of the COVID-19 BNT162b2 vaccine compared to those not treated with anti-TNFα (non-anti-TNFα) or to healthy controls (HCs). We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabinowitz, Keren Masha, Navon, Michal, Edelman-Klapper, Hadar, Zittan, Eran, Bar-Gil Shitrit, Ariella, Goren, Idan, Avni-Biron, Irit, Ollech, Jacob E., Lichtenstein, Lev, Banai-Eran, Hagar, Yanai, Henit, Snir, Yifat, Pauker, Maor H., Friedenberg, Adi, Levy-Barda, Adva, Segal, Arie, Broitman, Yelena, Maoz, Eran, Ovadia, Baruch, Aharoni Golan, Maya, Shachar, Eyal, Ben-Horin, Shomron, Maharshak, Nitsan, Mor, Michal, Ben Zvi, Haim, Eliakim, Rami, Barkan, Revital, Sharar-Fischler, Tali, Goren, Sophy, Krugliak, Noy, Pichinuk, Edward, Mor, Michael, Werbner, Michal, Alter, Joel, Abu-Taha, Hanan, Kaboub, Kawsar, Dessau, Moshe, Gal-Tanamy, Meital, Cohen, Dani, Freund, Natalia T., Dotan, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330864/
https://www.ncbi.nlm.nih.gov/pubmed/35893835
http://dx.doi.org/10.3390/vaccines10081186

Ejemplares similares

Ejemplares similares